118 related articles for article (PubMed ID: 7645979)
21. Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases.
Bendardaf R; Elzagheid A; Lamlum H; Algars A; Korkeila E; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S
Scand J Gastroenterol; 2007 Apr; 42(4):471-6. PubMed ID: 17454857
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
Lanza G; Maestri I; Dubini A; Gafà R
Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
[TBL] [Abstract][Full Text] [Related]
26. Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer.
Ishida Y; Kawakami K; Tanaka Y; Kanehira E; Omura K; Watanabe G
Anticancer Res; 2002; 22(5):2805-9. PubMed ID: 12530000
[TBL] [Abstract][Full Text] [Related]
27. Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal tumors.
Mini E; Biondi C; Morganti M; Napoli C; Mazzoni P; Cianchi F; Tonelli F; Cortesini C; Capaccioli S; Ficari F; Quattrone A; Rossi S; Mazzei T
Oncol Res; 1999; 11(9):437-45. PubMed ID: 10821538
[TBL] [Abstract][Full Text] [Related]
28. Do the expression of CD44, apoptosis and thymidylate synthase inhibition rate correlate with the efficacy of chemotherapy in colorectal cancer?
Tachikawa D; Arima S; Futami K; Iwashita A
Anticancer Res; 2000; 20(1C):595-600. PubMed ID: 10769701
[TBL] [Abstract][Full Text] [Related]
29. Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer.
Aschele C; Lonardi S; Monfardini S
Cancer Treat Rev; 2002 Feb; 28(1):27-47. PubMed ID: 12027413
[TBL] [Abstract][Full Text] [Related]
30. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
[TBL] [Abstract][Full Text] [Related]
31. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic value of DNA ploidy of colorectal tumor cells].
Givel JC; de Quay N; Albe X; Vassilakos P
Helv Chir Acta; 1989 Jan; 55(5):679-83. PubMed ID: 2715031
[TBL] [Abstract][Full Text] [Related]
33. Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma.
Berglund A; Edler D; Molin D; Nordlinder H; Graf W; Glimelius B
Anticancer Res; 2002; 22(6B):3653-9. PubMed ID: 12552972
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
35. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R
Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of thymidylate synthase as a prognostic factor and as a chemotherapeutic efficacy index in patients with colorectal carcinoma.
Tachikawa D; Arima S; Futami K
Anticancer Res; 2000; 20(6A):4103-7. PubMed ID: 11131679
[TBL] [Abstract][Full Text] [Related]
37. Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum.
Robey-Cafferty SS; el-Naggar AK; Grignon DJ; Cleary KR; Ro JY
Mod Pathol; 1990 May; 3(3):261-6. PubMed ID: 2362936
[TBL] [Abstract][Full Text] [Related]
38. Thymidylate synthase (TS) protein expression as a prognostic factor in advanced colorectal cancer: a comparison with TS mRNA expression.
Nakagawa T; Shimada M; Kurita N; Iwata T; Nishioka M; Yoshikawa K; Higashijima J; Utsunomiya T
Hepatogastroenterology; 2012 Jun; 59(116):1059-62. PubMed ID: 22580655
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer.
Karlberg M; Ohrling K; Edler D; Hallström M; Ullén H; Ragnhammar P
Anticancer Res; 2010 Feb; 30(2):645-51. PubMed ID: 20332484
[TBL] [Abstract][Full Text] [Related]
40. Relationship between thymidylate synthase (TS) genotype and TS expression: a tissue microarray analysis of colorectal cancers.
Popat S; Wort R; Houlston RS
Int J Surg Pathol; 2005 Apr; 13(2):127-33. PubMed ID: 15864374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]